Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects
dc.contributor.author | Zhao, Yingjie | |
dc.contributor.author | Diacou, Alexander | |
dc.contributor.author | Johnston, H. Richard | |
dc.contributor.author | Musfee, Fadi I | |
dc.contributor.author | McDonald-McGinn, Donna M. | |
dc.contributor.author | McGinn, Daniel | |
dc.contributor.author | Crowley, T. Blaine | |
dc.contributor.author | Repetto, Gabriela | |
dc.contributor.author | Swillen, Ann | |
dc.contributor.author | Breckpot, Jeroen | |
dc.contributor.author | Vermeesch, Joris R | |
dc.contributor.author | Kates, Wendy R. | |
dc.contributor.author | Digilio, M. Cristina | |
dc.contributor.author | Unolt, Marta | |
dc.contributor.author | Marino, Bruno | |
dc.contributor.author | Pontillo, Maria | |
dc.contributor.author | Armando, Marco | |
dc.contributor.author | Di Fabio, Fabio | |
dc.contributor.author | Vicari, Stefano | |
dc.contributor.author | Bree, Marianne van den | |
dc.contributor.author | Moss, Hayley | |
dc.contributor.author | Owen, Michael J. | |
dc.contributor.author | Murphy, Kieran C. | |
dc.contributor.author | Murphy, Clodagh M. | |
dc.contributor.author | Murphy, Declan | |
dc.contributor.author | Schoch, Kelly | |
dc.contributor.author | Shashi, Vandana | |
dc.contributor.author | Tassone, Flora | |
dc.contributor.author | Simon, Tony J. | |
dc.contributor.author | Shprintzen, Robert J. | |
dc.contributor.author | Campbell, Linda | |
dc.contributor.author | Philip, Nicole | |
dc.contributor.author | Heine-Suñer, Damian | |
dc.contributor.author | García-Miñaúr, Sixto | |
dc.contributor.author | Fernández, Luis | |
dc.contributor.author | Bearden, Carrie E. | |
dc.contributor.author | Vingerhoets, Claudia | |
dc.contributor.author | Amelsvoort, Therese van | |
dc.contributor.author | Eliez, Stephan | |
dc.contributor.author | Schneider, Maude | |
dc.contributor.author | Vorstman, Jacob A. S. | |
dc.contributor.author | Gothelf, Doron | |
dc.contributor.author | Zackai, Elaine | |
dc.contributor.author | Agopian, A. J. | |
dc.contributor.author | Gur, Raquel E. | |
dc.contributor.author | Bassett, Anne S. | |
dc.contributor.author | Emanuel, Beverly S. | |
dc.contributor.author | Goldmuntz, Elizabeth | |
dc.contributor.author | Mitchell, Laura E. | |
dc.contributor.author | Wang, Tao | |
dc.contributor.author | Morrow, Bernice E. | |
dc.date.accessioned | 2021-07-06T15:58:04Z | |
dc.date.available | 2021-07-06T15:58:04Z | |
dc.date.issued | 2020 | |
dc.description.abstract | The 22q11.2 deletion syndrome (22q11.2DS) results from non-allelic homologous recombination between low-copy repeats termed LCR22. About 60%-70% of individuals with the typical 3 megabase (Mb) deletion from LCR22A-D have congenital heart disease, mostly of the conotruncal type (CTD), whereas others have normal cardiac anatomy. In this study, we tested whether variants in the hemizygous LCR22A-D region are associated with risk for CTDs on the basis of the sequence of the 22q11.2 region from 1,053 22q11.2DS individuals. We found a significant association (FDR p < 0.05) of the CTD subset with 62 common variants in a single linkage disequilibrium (LD) block in a 350 kb interval harboring CRKL. A total of 45 of the 62 variants were associated with increased risk for CTDs (odds ratio [OR) ranges: 1.64-4.75). Associations of four variants were replicated in a meta-analysis of three genome-wide association studies of CTDs in affected individuals without 22q11.2DS. One of the replicated variants, rs178252, is located in an open chromatin region and resides in the double-elite enhancer, GH22J020947, that is predicted to regulate CRKL (CRK-like proto-oncogene, cytoplasmic adaptor) expression. Approximately 23% of patients with nested LCR22C-D deletions have CTDs, and inactivation of Crkl in mice causes CTDs, thus implicating this gene as a modifier. Rs178252 and rs6004160 are expression quantitative trait loci (eQTLs) of CRKL. Furthermore, set-based tests identified an enhancer that is predicted to target CRKL and is significantly associated with CTD risk (GH22J020946, sequence kernal association test (SKAT) p = 7.21 × 10-5) in the 22q11.2DS cohort. These findings suggest that variance in CTD penetrance in the 22q11.2DS population can be explained in part by variants affecting CRKL expression. | es |
dc.format.extent | 16 p. | es |
dc.identifier.citation | American Journal of Human Genetics . 2020 Jan 2;106(1):26-40 | es |
dc.identifier.uri | https://doi.org/10.1016/j.ajhg.2019.11.010 | es |
dc.identifier.uri | http://hdl.handle.net/11447/4133 | |
dc.language.iso | en | es |
dc.subject | CRKL | es |
dc.subject | DiGeorge syndrome | es |
dc.subject | TBX1 | es |
dc.subject | Chromosome 22q11.2 deletion syndrome | es |
dc.subject | Complex trait | es |
dc.subject | Congenital heart disease | es |
dc.subject | Conotruncal heart defects | es |
dc.subject | Copy number variation | es |
dc.subject | Genetic association | es |
dc.subject | Genetic modifier; haploinsufficiency. | es |
dc.subject | Haploinsufficiency | es |
dc.title | Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects | es |
dc.type | Article | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Complete Sequence of the 22q11.2 Allele...Modifiers of Conotruncal Heart Defects.pdf
- Size:
- 2.84 MB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: